Functional Involvement of IntegrinB4/ITGB4 and Kindlin/FERMT2 in Focal Adhesion Dynamic Remodeling in ARDS
IntegrinB4/ITGB4 和 Kindlin/FERMT2 在 ARDS 粘着动态重塑中的功能参与
基本信息
- 批准号:10871783
- 负责人:
- 金额:$ 40.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-20 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAccelerationActinsAcute Respiratory Distress SyndromeAddressAdhesionsAlternative SplicingAnti-Inflammatory AgentsAutomobile DrivingBindingBlood VesselsCOVID-19 pandemicCell Adhesion MoleculesCell membraneCellsChimeric ProteinsCodeComplexCytoplasmic TailCytoskeletal ProteinsCytoskeletonDNA MethylationEMS1 geneEndothelial CellsEndotheliumErinaceidaeFamily suidaeFocal AdhesionsFunctional disorderGenerationsGenesGeneticGenetic PolymorphismHIF1A geneInflammationInflammatoryIntegrin BindingIntegrin beta4IntegrinsIntercellular JunctionsLamininLiposomesLungMechanical StressMechanical ventilationMediatingModelingMolecularMultiple Organ FailurePTK2 genePeripheralPhosphorylationPost-Translational Protein ProcessingPre-Clinical ModelProteinsPulmonary CirculationRattusReactive Oxygen SpeciesRegulationRoleSignal TransductionSignaling MoleculeSimvastatinSiteStimulusStructureTherapeuticVariantVascular PermeabilitiesViralepigenetic regulationhealth disparityinhibitorinsightlink proteinlive cell imaginglung injurymechanotransductionmortalitymutantnitrationnovelpaxillinpharmacologicplectinporcine modelpre-clinicalpromoterrecruitresponserestorationtranscription factortranslational approachubiquitin-protein ligase
项目摘要
ABSTRACT:
The elevated ARDS mortality observed in the COVID-19 pandemic has highlighted the contribution of excessive
mechanical stress produced by mechanical ventilation in promoting lethal increases in lung vascular permea-
bility. Integrin β4 (ITGB4 gene) and kindlin-2 (FERMT2 gene) are essential adhesion molecules in endothelial
cell (EC) focal adhesions (FAs), structures critical for mechano-sensing, for bidirectional signaling between
the EC cytoskeleton and the cell-matrix interface, and for EC barrier regulation. The mechanistic basis for dy-
namic FA coordination during inflammatory EC barrier dysfunction and subsequent barrier restoration is a fun-
damental question that remains unresolved. We speculate that coordinate control of FA structures requires
the dynamic interactions of integrin β4 (ITGB4) and kindlin-2 with key PPG cytoskeletal effectors (nmMLCK,
cortactin, Dock1, lamellipodin, paxillin) to efficiently assemble functional FAs during EC barrier responses (pe-
ripheral cytoskeletal remodeling, lamellipodial formation, gap closure). ITGB4 is a unique mechano-sensing,
laminin-binding integrin, and kindlin-2 is a multi-domain mechano-sensing adapter FA protein that recruits struc-
tural and signaling molecules to FAs in concert with cytoskeletal rearrangement. We speculate that these EC
responses are highly influenced by ITGB4 and kindlin-2 post-translational modifications (PTMs) and coding pol-
ymorphisms (SNPs). As reactive oxygen species (ROS) is an important stimulus for FA dynamics and loss of
EC barrier integrity, with Core B, SA #1 will characterize the role of three ROS-sensing transcription factors
(NRF2, HIF1α/HIF2α), ITGB4/FERMT2 SNPs and DNA methylation in genetic/epigenetic regulation of
ITGB4/FERMT2 expression and the influence on generation of the unique ITGB4 alternatively-spliced, barrier-
regulatory variant, Integrin β4E (ITGB4E), that we identified as involved in mechano-sensing and EC barrier
regulation. With Core D, SA #2 will conduct in depth structure/function studies including 3D live cell imaging of
mutant ITGB4 and kindlin-2 fusion proteins (SNPs, PTMs) to characterize ITGB4/kindlin-2 function in spatially-
specific EC cytoskeletal rearrangements driving EC barrier-disruption and barrier-restoration. SA #3 will examine
the functionality of ITGB4/kindlin-2 interactions within lamellipodia with known and novel FA-binding cytoskeletal
partners, including cortactin, Dock1, lamellipodin and highly novel interactions with nmMLCK (Project #1).
Finally, utilizing elegant rat and porcine models of LPS/VILI (Core C), SA #4 will assess the therapeutic utility of
the SMURF inhibitor A01, or SRI-38832 to augment kindlin-2 expression as cargo in TySIPonate-conjugated
liposomes (TySIPosomes, Project #4). Project #3 studies will determine the structure/function and molecular
basis for the dynamic FA control by ITGB4 and kindlin-2 and yield important insights into functional relevance of
this unique FA signaling axis in restoration of EC barrier function. Our highly translational approaches will also
provide actionable EC barrier-regulatory strategies that restore the integrity of the injured pulmonary circulation
while yielding insights into ITGB4/FERMT2 variant participation in ARDS health disparities.
抽象的:
在 COVID-19 大流行中观察到的 ARDS 死亡率升高凸显了过度的贡献
机械通气产生的机械应力可促进肺血管通透性的致命增加
整合素 β4(ITGB4 基因)和 kindlin-2(FERMT2 基因)是内皮细胞中必需的粘附分子。
细胞(EC)粘着斑(FA),对于机械传感、之间的双向信号传递至关重要的结构
EC 细胞骨架和细胞基质界面,以及 EC 屏障调节。
炎症性 EC 屏障功能障碍和随后的屏障恢复期间的纳米 FA 协调是一个有趣的过程
我们推测 FA 结构需要协调控制。
整合素 β4 (ITGB4) 和 kindlin-2 与关键 PPG 细胞骨架效应器 (nmMLCK、
cortactin、Dock1、lamellipodin、paxillin)可在 EC 屏障反应期间有效组装功能性 FA(pe-
ITGB4 是一种独特的机械传感、
kindlin-2 是一种多结构域机械传感适配器 FA 蛋白,可招募结构域
我们推测这些 EC 与 FA 的结合和信号分子与细胞骨架重排相一致。
反应很大程度上受到 ITGB4 和 kindlin-2 翻译后修饰 (PTM) 和编码 pol 的影响。
活性氧 (ROS) 是 FA 动力学和丧失的重要刺激因素。
EC 屏障完整性,核心 B,SA #1 将表征三个 ROS 感应转录因子的作用
(NRF2、HIF1α/HIF2α)、ITGB4/FERMT2 SNP 和 DNA 甲基化在遗传/表观遗传调控中的作用
ITGB4/FERMT2 表达及其对独特 ITGB4 选择性剪接、屏障-生成的影响
调节变体整合素 β4E (ITGB4E),我们确定其参与机械传感和 EC 屏障
借助 Core D,SA #2 将进行深度结构/功能研究,包括 3D 活细胞成像。
突变 ITGB4 和 kindlin-2 融合蛋白(SNP、PTM),用于表征 ITGB4/kindlin-2 在空间上的功能
SA #3 将检查驱动 EC 屏障破坏和屏障恢复的特定 EC 细胞骨架重排。
板状伪足内 ITGB4/kindlin-2 与已知和新型 FA 结合细胞骨架相互作用的功能
合作伙伴,包括 cortactin、Dock1、lamellipodin 以及与 nmMLCK 的高度新颖的相互作用(项目 #1)。
最后,利用 LPS/VILI(核心 C)的优雅大鼠和猪模型,SA #4 将评估以下药物的治疗效用:
SMURF 抑制剂 A01 或 SRI-38832 增强 Kindlin-2 表达,作为 TySIPonate 缀合的货物
脂质体(TySIPosomes,项目#4)。项目#3 研究将确定其结构/功能和分子。
ITGB4 和 kindlin-2 动态 FA 控制的基础,并对功能相关性产生重要见解
这种独特的 FA 信号轴在恢复 EC 屏障功能方面也将发挥作用。
提供可行的 EC 屏障调节策略,恢复受损肺循环的完整性
同时深入了解 ITGB4/FERMT2 变异参与 ARDS 健康差异的情况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANNE E CRESS其他文献
ANNE E CRESS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANNE E CRESS', 18)}}的其他基金
Centrosome instability as a mechanism to promote localized prostate cancer
中心体不稳定是促进局部前列腺癌的机制
- 批准号:
10226121 - 财政年份:2019
- 资助金额:
$ 40.52万 - 项目类别:
Centrosome instability as a mechanism to promote localized prostate cancer
中心体不稳定是促进局部前列腺癌的机制
- 批准号:
10453728 - 财政年份:2019
- 资助金额:
$ 40.52万 - 项目类别:
Centrosome instability as a mechanism to promote localized prostate cancer
中心体不稳定是促进局部前列腺癌的机制
- 批准号:
9815223 - 财政年份:2019
- 资助金额:
$ 40.52万 - 项目类别:
Centrosome instability as a mechanism to promote localized prostate cancer
中心体不稳定是促进局部前列腺癌的机制
- 批准号:
10664978 - 财政年份:2019
- 资助金额:
$ 40.52万 - 项目类别:
Centrosome instability as a mechanism to promote localized prostate cancer
中心体不稳定是促进局部前列腺癌的机制
- 批准号:
10001057 - 财政年份:2019
- 资助金额:
$ 40.52万 - 项目类别:
Human Prostate Cancer Metastasis and Laminin Binding Integrins
人类前列腺癌转移和层粘连蛋白结合整合素
- 批准号:
8468666 - 财政年份:2011
- 资助金额:
$ 40.52万 - 项目类别:
Human Prostate Cancer Metastasis and Laminin Binding Integrins
人类前列腺癌转移和层粘连蛋白结合整合素
- 批准号:
8677801 - 财政年份:2011
- 资助金额:
$ 40.52万 - 项目类别:
Human Prostate Cancer Metastasis and Laminin Binding Integrins
人类前列腺癌转移和层粘连蛋白结合整合素
- 批准号:
8113477 - 财政年份:2011
- 资助金额:
$ 40.52万 - 项目类别:
Human Prostate Cancer Metastasis and Laminin Binding Integrins
人类前列腺癌转移和层粘连蛋白结合整合素
- 批准号:
8307309 - 财政年份:2011
- 资助金额:
$ 40.52万 - 项目类别:
Cellular Adhesion and Prostate Tumor Progression
细胞粘附和前列腺肿瘤进展
- 批准号:
6990126 - 财政年份:2004
- 资助金额:
$ 40.52万 - 项目类别:
相似国自然基金
高功率激光驱动低β磁重联中磁岛对电子加速影响的研究
- 批准号:12305275
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
U型离散顺流火蔓延非稳态热输运机理与加速机制研究
- 批准号:52308532
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
实施科学视角下食管癌加速康复外科证据转化障碍机制与多元靶向干预策略研究
- 批准号:82303925
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TWIST1介导的ITGBL1+肿瘤相关成纤维细胞转化加速结肠癌动态演化进程机制及其预防干预研究
- 批准号:82373112
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
NOTCH3/HLF信号轴驱动平滑肌细胞表型转化加速半月板退变的机制研究
- 批准号:82372435
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Unanticipated roles of C5aR1 Signaling Leading from Acute to Chronic Kidney Disease
C5aR1 信号转导从急性肾病到慢性肾病的意外作用
- 批准号:
10591053 - 财政年份:2023
- 资助金额:
$ 40.52万 - 项目类别:
Mechanisms of cardiomyocyte dysfunction due to the E258K-MYBPC3 mutation modeled in patient-derived cardiomyocytes
在患者来源的心肌细胞中建模 E258K-MYBPC3 突变引起的心肌细胞功能障碍的机制
- 批准号:
10794930 - 财政年份:2022
- 资助金额:
$ 40.52万 - 项目类别:
New Methods and Tools for Computational Drug Discovery
计算药物发现的新方法和工具
- 批准号:
10633106 - 财政年份:2021
- 资助金额:
$ 40.52万 - 项目类别:
Impact of ALS-linked mutations on the structure, dynamics and function of profilin-1
ALS 相关突变对 profilin-1 结构、动力学和功能的影响
- 批准号:
10533362 - 财政年份:2021
- 资助金额:
$ 40.52万 - 项目类别:
Hybrid Hydrogel Biomaterials Comprising Clickable Decellularized Extracellular Matrix for Engineering Dynamic 3D Models of Fibrosis
包含可点击脱细胞细胞外基质的混合水凝胶生物材料,用于工程纤维化动态 3D 模型
- 批准号:
10661783 - 财政年份:2020
- 资助金额:
$ 40.52万 - 项目类别: